Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort
Abstract Background Adverse drug reactions (ADRs) are the sixth leading causes of death worldwide; monitoring them is fundamental, especially in patients with disorders like chronic rheumatic diseases (CRDs). The study aimed to describe the ADRs investigating their severity and associated factors an...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-11-01
|
| Series: | Advances in Rheumatology |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s42358-020-00154-4 |
| _version_ | 1818342627927392256 |
|---|---|
| author | Manar Amanouil Said Liana Soido Teixeira e Silva Aline Maria de Oliveira Rocha Gustavo Guimarães Barreto Alves Daniela Gerent Petry Piotto Claudio Arnaldo Len Maria Teresa Terreri |
| author_facet | Manar Amanouil Said Liana Soido Teixeira e Silva Aline Maria de Oliveira Rocha Gustavo Guimarães Barreto Alves Daniela Gerent Petry Piotto Claudio Arnaldo Len Maria Teresa Terreri |
| author_sort | Manar Amanouil Said |
| collection | DOAJ |
| description | Abstract Background Adverse drug reactions (ADRs) are the sixth leading causes of death worldwide; monitoring them is fundamental, especially in patients with disorders like chronic rheumatic diseases (CRDs). The study aimed to describe the ADRs investigating their severity and associated factors and resulting interventions in pediatric patients with CRDs. Methods A retrospective, descriptive and analytical study was conducted on a cohort of children and adolescents with juvenile idiopathic arthritis (JIA), juvenile systemic lupus erythematosus (JSLE) and juvenile dermatomyositis (JDM). The study evaluated medical records of the patients to determine the causality and the management of ADRs. In order to investigate the risk factors that would increase the risk of ADRs, a logistic regression model was carried out on a group of patients treated with the main used drug. Results We observed 949 ADRs in 547 patients studied. Methotrexate (MTX) was the most frequently used medication and also the cause of the most ADRs, which occurred in 63.3% of patients, followed by glucocorticoids (GCs). Comparing synthetic disease-modifying anti-rheumatic drugs (sDMARDs) vs biologic disease-modifying anti-rheumatic drugs (bDMARDs), the ADRs attributed to the former were by far higher than the latter. In general, the severity of ADRs was moderate and manageable. Drug withdrawal occurred in almost a quarter of the cases. In terms of risk factors, most patients who experienced ADRs due to MTX, were 16 years old or younger and received MTX in doses equal or higher than 0.6 mg/kg/week. Patients with JIA and JDM had a lower risk of ADRs than patients with JSLE. In the multiple regression model, the use of GCs for over 6 months led to an increase of 0.5% in the number of ADRs. Conclusions Although the ADRs highly likely affect a wide range of children and adolescents with CRDs they were considered moderate and manageable cases mostly. However, triggers of ADRs need further investigations. |
| first_indexed | 2024-12-13T16:17:42Z |
| format | Article |
| id | doaj.art-55443831bf69462d8c7a5c67412cd034 |
| institution | Directory Open Access Journal |
| issn | 2523-3106 |
| language | English |
| last_indexed | 2024-12-13T16:17:42Z |
| publishDate | 2020-11-01 |
| publisher | BMC |
| record_format | Article |
| series | Advances in Rheumatology |
| spelling | doaj.art-55443831bf69462d8c7a5c67412cd0342022-12-21T23:38:49ZengBMCAdvances in Rheumatology2523-31062020-11-0160111110.1186/s42358-020-00154-4Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohortManar Amanouil Said0Liana Soido Teixeira e Silva1Aline Maria de Oliveira Rocha2Gustavo Guimarães Barreto Alves3Daniela Gerent Petry Piotto4Claudio Arnaldo Len5Maria Teresa Terreri6Division of Pediatric Rheumatology, Department of Pediatrics, Federal University Sao Paulo (Unifesp)Division of Pediatric Rheumatology, Department of Pediatrics, Federal University Sao Paulo (Unifesp)Division of Pediatric Rheumatology, Department of Pediatrics, Federal University Sao Paulo (Unifesp)Division of Pediatric Rheumatology, Department of Pediatrics, Federal University Sao Paulo (Unifesp)Division of Pediatric Rheumatology, Department of Pediatrics, Federal University Sao Paulo (Unifesp)Division of Pediatric Rheumatology, Department of Pediatrics, Federal University Sao Paulo (Unifesp)Division of Pediatric Rheumatology, Department of Pediatrics, Federal University Sao Paulo (Unifesp)Abstract Background Adverse drug reactions (ADRs) are the sixth leading causes of death worldwide; monitoring them is fundamental, especially in patients with disorders like chronic rheumatic diseases (CRDs). The study aimed to describe the ADRs investigating their severity and associated factors and resulting interventions in pediatric patients with CRDs. Methods A retrospective, descriptive and analytical study was conducted on a cohort of children and adolescents with juvenile idiopathic arthritis (JIA), juvenile systemic lupus erythematosus (JSLE) and juvenile dermatomyositis (JDM). The study evaluated medical records of the patients to determine the causality and the management of ADRs. In order to investigate the risk factors that would increase the risk of ADRs, a logistic regression model was carried out on a group of patients treated with the main used drug. Results We observed 949 ADRs in 547 patients studied. Methotrexate (MTX) was the most frequently used medication and also the cause of the most ADRs, which occurred in 63.3% of patients, followed by glucocorticoids (GCs). Comparing synthetic disease-modifying anti-rheumatic drugs (sDMARDs) vs biologic disease-modifying anti-rheumatic drugs (bDMARDs), the ADRs attributed to the former were by far higher than the latter. In general, the severity of ADRs was moderate and manageable. Drug withdrawal occurred in almost a quarter of the cases. In terms of risk factors, most patients who experienced ADRs due to MTX, were 16 years old or younger and received MTX in doses equal or higher than 0.6 mg/kg/week. Patients with JIA and JDM had a lower risk of ADRs than patients with JSLE. In the multiple regression model, the use of GCs for over 6 months led to an increase of 0.5% in the number of ADRs. Conclusions Although the ADRs highly likely affect a wide range of children and adolescents with CRDs they were considered moderate and manageable cases mostly. However, triggers of ADRs need further investigations.http://link.springer.com/article/10.1186/s42358-020-00154-4Autoimmune rheumatic diseasesPharmacosurveillanceAdverse drug reactionsBiological agentsChildhood |
| spellingShingle | Manar Amanouil Said Liana Soido Teixeira e Silva Aline Maria de Oliveira Rocha Gustavo Guimarães Barreto Alves Daniela Gerent Petry Piotto Claudio Arnaldo Len Maria Teresa Terreri Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort Advances in Rheumatology Autoimmune rheumatic diseases Pharmacosurveillance Adverse drug reactions Biological agents Childhood |
| title | Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort |
| title_full | Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort |
| title_fullStr | Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort |
| title_full_unstemmed | Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort |
| title_short | Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort |
| title_sort | adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood a retrospective real life review of a single center cohort |
| topic | Autoimmune rheumatic diseases Pharmacosurveillance Adverse drug reactions Biological agents Childhood |
| url | http://link.springer.com/article/10.1186/s42358-020-00154-4 |
| work_keys_str_mv | AT manaramanouilsaid adversedrugreactionsassociatedwithtreatmentinpatientswithchronicrheumaticdiseasesinchildhoodaretrospectivereallifereviewofasinglecentercohort AT lianasoidoteixeiraesilva adversedrugreactionsassociatedwithtreatmentinpatientswithchronicrheumaticdiseasesinchildhoodaretrospectivereallifereviewofasinglecentercohort AT alinemariadeoliveirarocha adversedrugreactionsassociatedwithtreatmentinpatientswithchronicrheumaticdiseasesinchildhoodaretrospectivereallifereviewofasinglecentercohort AT gustavoguimaraesbarretoalves adversedrugreactionsassociatedwithtreatmentinpatientswithchronicrheumaticdiseasesinchildhoodaretrospectivereallifereviewofasinglecentercohort AT danielagerentpetrypiotto adversedrugreactionsassociatedwithtreatmentinpatientswithchronicrheumaticdiseasesinchildhoodaretrospectivereallifereviewofasinglecentercohort AT claudioarnaldolen adversedrugreactionsassociatedwithtreatmentinpatientswithchronicrheumaticdiseasesinchildhoodaretrospectivereallifereviewofasinglecentercohort AT mariateresaterreri adversedrugreactionsassociatedwithtreatmentinpatientswithchronicrheumaticdiseasesinchildhoodaretrospectivereallifereviewofasinglecentercohort |